HB

Haresh Budhia Machhi

Active Director Director DIN 00818849
DIN 00818849 First appointment Dec 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Haresh Budhia Machhi

Data last updated:

Haresh Budhia Machhi is a Director at Deevyalok Pharma Private Limited (since 2006). The company operates in Pharma.

DIN 00818849
Primary Designation Director
Industry Pharma
First Appointment 01 Dec 2006
Oldest Company Age 42 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Deevyalok Pharma Private Limited U24100MH1984PTC032423
Director01 Dec 20061984Active

Directorship timeline

Open interactive timeline →
Deevyalok Pharma Private Limited
Premium access

Shareholding and investment profile for Haresh Budhia Machhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Haresh Budhia Machhi

Haresh Budhia Machhi currently holds 1 directorship: Deevyalok Pharma Private Limited (Director, since 01 Dec 2006).

Haresh Budhia Machhi was first appointed on 01 Dec 2006 as Director at Deevyalok Pharma Private Limited.

The current boards of Haresh Budhia Machhi's companies include Chhailbihari Ramlagan Upadhyay (Deevyalok Pharma Private Limited), Kamalahmad Jalalahmed Khan (Deevyalok Pharma Private Limited), Kamlesh Ramubhai Jaiswal (Deevyalok Pharma Private Limited), Vimal Upadhyay (Deevyalok Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available